Jane Street’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-41,600
Closed -$4.99K 10331
2022
Q4
$4.99K Hold
41,600
﹤0.01% 8860
2022
Q3
$7K Sell
41,600
-6,300
-13% -$3.39K ﹤0.01% 9412
2022
Q2
$85K Sell
47,900
-222,800
-82% -$500K ﹤0.01% 8729
2022
Q1
$815K Sell
270,700
-25,200
-9% -$67.4K ﹤0.01% 6550
2021
Q4
$1.1M Buy
295,900
+138,700
+88% +$811K ﹤0.01% 5697
2021
Q3
$932K Buy
157,200
+68,100
+76% +$957K ﹤0.01% 6051
2021
Q2
$1.55M Sell
89,100
-32,100
-26% -$585K ﹤0.01% 4852
2021
Q1
$2.31M Buy
+121,200
New +$2.21M ﹤0.01% 3741

Other funds holding HGEN

Jane Street's HGEN Position: Q1 2023 in Review

Jane Street sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 19,768 shares — an estimated $2.37K sold.

Jane Street first reported a position in HGEN in Q1 2021 and held it in 7 quarters. The position peaked at $4.11M in Q2 2021. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

  • Jane Street reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 19,768 HUMANIGEN, INC. shares in Q1 2023, an estimated $2.37K.
  • Jane Street first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 7 quarters.
  • Jane Street's HUMANIGEN, INC. position peaked at $4.11M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.